Clinical Trials in Cleveland

Showing 6561-6580 of 15,050 trials

Treatment of Diabetic Macular Edema With Aflibercept in Subjects Previously Treated With Ranibizumab or Bevacizumab

NCT02559180

Treatment of diabetic macular edema with intravitreal aflibercept in subjects previously treated with intravitreal anti-Vascular endothelial growth factor (VEGF) agents (ranibizumab or bevacizumab)

Diabetic RetinopathyMacular Edema

Rishi Singh20 participantsStarted Oct 2015

Cleveland, Ohio, United States

COMPLETEDPhase 3< 1 mile

An Investigational Immuno-therapy Study of Nivolumab Compared to Temozolomide, Each Given With Radiation Therapy, for Newly-diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)

NCT02617589

The purpose of this study is to evaluate patients with glioblastoma that is MGMT-unmethylated (the MGMT gene is not altered by a chemical change). Patients will receive Nivolumab every two weeks in addition to radiation therapy, and then every four weeks. They will be compared to patients receiving standard therapy with temozolomide in addition to radiation therapy.

Brain Cancer

Bristol-Myers Squibb560 participantsStarted Mar 2016

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Los Angeles, California, United States +122 more locations

Treatment of Diabetic Macular Edema With Aflibercept in Subjects Previously Treated With Ranibizumab or Bevacizumab

An Investigational Immuno-therapy Study of Nivolumab Compared to Temozolomide, Each Given With Radiation Therapy, for Newly-diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)

Find Trials by Condition in Cleveland

Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial

OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules

A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors

Study to Assess Efficacy and Safety of Inhaled Interferon-β Therapy for COVID-19

An Extension Trial of Inclisiran in Participants With Cardiovascular Disease and High Cholesterol

An Investigational Immuno-therapy Study of Nivolumab, Pomalidomide and Dexamethasone Combinations in Patients With Multiple Myeloma

Phase 1 Study of RBN-2397, an Oral PARP7 Inhibitor, in Patients With Solid Tumors

A Study of PRT543 in Participants With Advanced Solid Tumors and Hematologic Malignancies

A Study of Lanadelumab in Persons With Hereditary Angioedema (HAE) Type I or II in North America

A Study to Test the Effectiveness and Safety of Fremanezumab on Participants With Fibromyalgia

S1316, Surgery or Non-Surgical Management in Treating Patients With Intra-Abdominal Cancer and Bowel Obstruction

Comparison of Sleep Apnea Assessment Strategies to Maximize TBI Rehabilitation Participation and Outcome

3D Prediction of Patient-Specific Response

A Single-Arm Study of Bempegaldesleukin (NKTR-214) Plus Nivolumab in Cisplatin Ineligible Patients Who Have Locally Advanced or Metastatic Urothelial Cancer

Islatravir (MK-8591) With Doravirine and Lamivudine in Participants Infected With Human Immunodeficiency Virus Type 1 (MK-8591-011)

Bioavailability of EPA + DHA in a SMEDS Formulation

A Study of EDP1503 in Patients With Colorectal Cancer, Breast Cancer, and Checkpoint Inhibitor Relapsed Tumors

A Study of Bempegaldesleukin (BEMPEG: NKTR-214) in Combination With Nivolumab in Children, Adolescents and Young Adults With Recurrent or Treatment-resistant Cancer